vs

Side-by-side financial comparison of CF Industries (CF) and ICAHN ENTERPRISES L.P. (IEP). Click either name above to swap in a different company.

ICAHN ENTERPRISES L.P. is the larger business by last-quarter revenue ($2.7B vs $1.9B, roughly 1.4× CF Industries). CF Industries runs the higher net margin — 26.4% vs 0.0%, a 26.4% gap on every dollar of revenue. On growth, CF Industries posted the faster year-over-year revenue change (22.8% vs 5.4%). CF Industries produced more free cash flow last quarter ($313.0M vs $-496.0M). Over the past eight quarters, CF Industries's revenue compounded faster (12.8% CAGR vs 4.5%).

CF Industries Holdings, Inc. is an American manufacturer and distributor of agricultural fertilizers, including ammonia, urea, and ammonium nitrate products. The company is based in Northbrook, Illinois, a suburb of Chicago, and was founded in 1946 as the Central Farmers Fertilizer Company. For its first 56 years, it was a federation of regional agricultural supply cooperatives. CF then demutualized, and became a publicly traded company.

Icahn Enterprises L.P. is an American publicly traded master limited partnership and conglomerate headquartered at Milton Tower in Sunny Isles Beach, Florida. The company has investments in various industries including energy, automotive, food packaging, metals, real estate and home fashion. The company is controlled by Carl Icahn, who owns 86 percent of it.

CF vs IEP — Head-to-Head

Bigger by revenue
IEP
IEP
1.4× larger
IEP
$2.7B
$1.9B
CF
Growing faster (revenue YoY)
CF
CF
+17.5% gap
CF
22.8%
5.4%
IEP
Higher net margin
CF
CF
26.4% more per $
CF
26.4%
0.0%
IEP
More free cash flow
CF
CF
$809.0M more FCF
CF
$313.0M
$-496.0M
IEP
Faster 2-yr revenue CAGR
CF
CF
Annualised
CF
12.8%
4.5%
IEP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CF
CF
IEP
IEP
Revenue
$1.9B
$2.7B
Net Profit
$495.0M
$1.0M
Gross Margin
40.9%
Operating Margin
33.0%
0.6%
Net Margin
26.4%
0.0%
Revenue YoY
22.8%
5.4%
Net Profit YoY
26.3%
101.0%
EPS (diluted)
$2.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CF
CF
IEP
IEP
Q4 25
$1.9B
$2.7B
Q3 25
$1.7B
$2.7B
Q2 25
$1.9B
$2.4B
Q1 25
$1.7B
$1.9B
Q4 24
$1.5B
$2.6B
Q3 24
$1.4B
$2.8B
Q2 24
$1.6B
$2.2B
Q1 24
$1.5B
$2.5B
Net Profit
CF
CF
IEP
IEP
Q4 25
$495.0M
$1.0M
Q3 25
$460.0M
$287.0M
Q2 25
$492.0M
$-165.0M
Q1 25
$351.0M
$-422.0M
Q4 24
$392.0M
$-98.0M
Q3 24
$341.0M
$22.0M
Q2 24
$506.0M
$-331.0M
Q1 24
$238.0M
$-38.0M
Gross Margin
CF
CF
IEP
IEP
Q4 25
40.9%
Q3 25
38.1%
Q2 25
39.9%
Q1 25
34.4%
Q4 24
34.4%
Q3 24
32.4%
Q2 24
43.2%
Q1 24
27.8%
Operating Margin
CF
CF
IEP
IEP
Q4 25
33.0%
0.6%
Q3 25
35.0%
19.7%
Q2 25
34.3%
-10.4%
Q1 25
27.4%
-35.0%
Q4 24
28.9%
-5.2%
Q3 24
26.6%
2.4%
Q2 24
40.6%
-21.9%
Q1 24
20.6%
-0.8%
Net Margin
CF
CF
IEP
IEP
Q4 25
26.4%
0.0%
Q3 25
27.7%
10.5%
Q2 25
26.0%
-7.0%
Q1 25
21.1%
-22.6%
Q4 24
25.7%
-3.8%
Q3 24
24.9%
0.8%
Q2 24
32.2%
-15.0%
Q1 24
16.2%
-1.5%
EPS (diluted)
CF
CF
IEP
IEP
Q4 25
$2.56
Q3 25
$2.19
Q2 25
$2.37
Q1 25
$1.85
Q4 24
$1.86
Q3 24
$1.55
Q2 24
$2.30
Q1 24
$1.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CF
CF
IEP
IEP
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$4.8B
Total Assets
$14.1B
$14.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CF
CF
IEP
IEP
Q4 25
$1.4B
Q3 25
$1.8B
Q2 25
$1.8B
Q1 25
$2.2B
Q4 24
$2.6B
Q3 24
$2.3B
Q2 24
$2.2B
Q1 24
$2.5B
Total Debt
CF
CF
IEP
IEP
Q4 25
$3.2B
Q3 25
$3.0B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$3.0B
Q2 24
$3.0B
Q1 24
$3.0B
Stockholders' Equity
CF
CF
IEP
IEP
Q4 25
$4.8B
Q3 25
$4.8B
Q2 25
$5.0B
Q1 25
$4.8B
Q4 24
$5.0B
Q3 24
$5.2B
Q2 24
$5.5B
Q1 24
$5.4B
Total Assets
CF
CF
IEP
IEP
Q4 25
$14.1B
$14.2B
Q3 25
$14.2B
$14.8B
Q2 25
$13.8B
$14.8B
Q1 25
$13.3B
$15.5B
Q4 24
$13.5B
$16.3B
Q3 24
$13.8B
$17.4B
Q2 24
$13.8B
$18.0B
Q1 24
$13.9B
$20.1B
Debt / Equity
CF
CF
IEP
IEP
Q4 25
0.66×
Q3 25
0.61×
Q2 25
0.60×
Q1 25
0.62×
Q4 24
0.60×
Q3 24
0.57×
Q2 24
0.54×
Q1 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CF
CF
IEP
IEP
Operating Cash FlowLast quarter
$539.0M
$-421.0M
Free Cash FlowOCF − Capex
$313.0M
$-496.0M
FCF MarginFCF / Revenue
16.7%
-18.4%
Capex IntensityCapex / Revenue
12.1%
2.8%
Cash ConversionOCF / Net Profit
1.09×
-421.00×
TTM Free Cash FlowTrailing 4 quarters
$1.8B
$-654.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CF
CF
IEP
IEP
Q4 25
$539.0M
$-421.0M
Q3 25
$1.1B
$15.0M
Q2 25
$563.0M
$275.0M
Q1 25
$586.0M
$-182.0M
Q4 24
$420.0M
$244.0M
Q3 24
$931.0M
$-54.0M
Q2 24
$475.0M
$893.0M
Q1 24
$445.0M
$-251.0M
Free Cash Flow
CF
CF
IEP
IEP
Q4 25
$313.0M
$-496.0M
Q3 25
$717.0M
$-67.0M
Q2 25
$318.0M
$179.0M
Q1 25
$454.0M
$-270.0M
Q4 24
$223.0M
$156.0M
Q3 24
$792.0M
$-112.0M
Q2 24
$391.0M
$827.0M
Q1 24
$347.0M
$-319.0M
FCF Margin
CF
CF
IEP
IEP
Q4 25
16.7%
-18.4%
Q3 25
43.2%
-2.5%
Q2 25
16.8%
7.6%
Q1 25
27.3%
-14.5%
Q4 24
14.6%
6.1%
Q3 24
57.8%
-4.0%
Q2 24
24.9%
37.6%
Q1 24
23.6%
-12.9%
Capex Intensity
CF
CF
IEP
IEP
Q4 25
12.1%
2.8%
Q3 25
20.9%
3.0%
Q2 25
13.0%
4.1%
Q1 25
7.9%
4.7%
Q4 24
12.9%
3.4%
Q3 24
10.1%
2.1%
Q2 24
5.3%
3.0%
Q1 24
6.7%
2.8%
Cash Conversion
CF
CF
IEP
IEP
Q4 25
1.09×
-421.00×
Q3 25
2.31×
0.05×
Q2 25
1.14×
Q1 25
1.67×
Q4 24
1.07×
Q3 24
2.73×
-2.45×
Q2 24
0.94×
Q1 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CF
CF

Ammonia$591.0M32%
UAN$493.0M26%
Urea$372.0M20%
Other$244.0M13%
Other Products$147.0M8%
Ammonium Nitrate Segment$25.0M1%

IEP
IEP

Public Utilities Inventory Petroleum Products$1.6B61%
Other$381.0M14%
Automotive Services$345.0M13%
Nitrogen Fertilizer Products$131.0M5%
Food Packaging Segment$82.0M3%
Home Fashion Segment$45.0M2%
Renewable Products$32.0M1%
Pharma Segment$23.0M1%
Holding Company$11.0M0%

Related Comparisons